Healthcare - Press Releases

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global healthcare IT marketsize is estimated to grow by USD 215.4 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of almost11.4% during the forecast period. Increasing focus on improving quality of services and efficiencyis driving market growth,with a trend towardsemergence of ai-enabled emotion recognition technologies. However,vulnerability of emrs toward cybercrime poses a challenge. Key market players include 3M Co., athenahealth Inc., Cognizant Technology Solutions Corp., Dassault Systemes SE, Datavant, Dell Technologies Inc., Epic Systems Corp., GE Healthcare Technologies Inc., International Business Machines Corp., Koninklijke Philips NV, McKesson Corp., Microsoft Corp., Oracle Corp., SAS Institute Inc., Siemens AG, Tata Consultancy Services Ltd., Tenet Healthcare Corp., Optum Inc., Veradigm LLC, and Wipro Ltd..

SANTA MONICA, Calif., Feb. 7, 2025 /PRNewswire/ -- Skin by Lovely and Corrective Skincare LA, two renowned names in Los Angeles skincare, are excited to announce their merger. This partnership combines expertise in non-surgical facial rejuvenation and advanced acne care to revolutionize skin health. This union merges Skin by Lovely's leadership as one of the largest BOTOX providers in the United States with Corrective Skincare LA's decades-long reputation as specialists in skin health and transformation since 1996.

CHENGDU, China, Feb. 7, 2025 /PRNewswire/ -- KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart (anti-IL-4R monoclonal antibody, trade name: Kangyueda (), for the treatment of seasonal allergic rhinitis.

CHENGDU, China, Feb. 8, 2025 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart (anti-IL-4R monoclonal antibody, trade name: Kangyueda (), for the treatment of seasonal allergic rhinitis.

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //

Search for Chief Executive Officer to commence immediately

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global healthcare services marketsize is estimated to grow by USD 6.26 trillion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.73% during the forecast period. Increasing prevalence of chronic diseasesis driving market growth,with a trend towardsrise in adoption of telemedicine in healthcare sector.However,increasing healthcare costs poses a challenge. Key market players include Apollo Hospitals Enterprise Ltd, athenahealth Inc., Community Health Systems Inc., CVS Health Corp., DaVita Inc., Dr Lal PathLabs Ltd., Expedient Healthcare Marketing Pvt. Ltd., Fresenius Medical Care AG and Co. KGaA, Genesis Healthcare Inc., iHealth Labs Inc., Max Healthcare Institute Ltd, Mayo Foundation for Medical Education and Research, McKesson Corp., OMH HealthEdge Holdings LLC, Optum Inc., Quest Diagnostics Inc., Sonic Healthcare Ltd., Universal Health Services Inc., and West Suffolk NHS Foundation Trust.

NEW YORK, Feb. 8, 2025 /PRNewswire/ --Report on how AI is driving market transformation - The globalsenior living market size is estimated to grow by USD 130.9 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 5.8% during the forecast period. Aging baby boomer populationis driving market growth,with a trend towardsincreasing technological advances in long-term healthcare. However,staffing and workplace challenges poses a challenge. Key market players include AbsoluteCare Inc., Affinity Living Communities, Belmont Village Senior Living, Brookdale Senior Living Inc., Covenant Living Communities and Services, Enterprise Retirement Living Ltd., Erickson Senior Living Management LLC, Extendicare Canada Inc, Genesis Healthcare Inc., Golden Heights Personal Care Home, Grand world Elder Care, HC One Ltd., Lendlease Corp. Ltd., Life Care Centers of America Inc., Merrill Gardens, Max India Ltd., ProMedica Health Systems Inc., Senior Lifestyle, Sunrise Senior Living LLC, and Wickshire Senior Living.

Transforming Pet Care into a Magical Adventure:HICC Pet offers spa-like grooming and healthcare while educating pet owners on maintaining their pets' wellness.

NEW YORK, Feb. 9, 2025 /PRNewswire/ -- "The announcement from the National Institutes of Health (NIH) that they are dramatically reducing funding for indirect costs for research grants is a threat to research that will disrupt critical medical advances. Funding for indirect costs is essential funding because it pays for the infrastructure that is required to make research possible.

SHANGHAI, Feb. 9, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first subject treated with an allogeneic BCMA CAR-T therapy developed on the THANK-u Plus platform, has achieved stringent complete response (sCR) and minimal residual disease (MRD) negativity at the Day-28 assessment.

SUZHOU, China, Feb. 9, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that its key product, Cejemly(sugemalimab), has been included in theEuropean Society for Medical Oncology (ESMO) Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer(NSCLC) Living Guideline. Sugemalimab is recommended as a first-line combination therapy for both squamous and non-squamous NSCLC, with substantial clinical benefits. This is a significant milestone in sugemalimab's global journey and provides critical support for our efforts to expand market access, enter the markets, and reach patients.

PARIS, Feb. 10, 2025 /PRNewswire/ -- 2025 IMCAS World Congress, the world's largest scientific aesthetics congress, was grandly held in Paris from January 30 to February 1, celebrating its 26th anniversary.

CHENGDU, Chine, 10 fvrier 2025 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) a annonc aujourd'hui que la National Medical Products Administration (la NMPA) de Chine a rcemment approuv la demande supplmentaire de nouveau mdicament (la sNDA) pour le Stapokibart (anticorps monoclonal anti-IL-4R, nom commercial: Kangyueda, ), pour le traitement de la rhinite allergique saisonnire.

CHENGDU, China, 10. Februar 2025 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) gab heute bekannt, dass die National Medical Products Administration (die NMPA") von China vor kurzem den ergnzenden Antrag fr ein neues Arzneimittel (die sNDA") von Stapokibart (monoklonaler Antikrper gegen IL-4R, Handelsname: Kangyueda (), zur Behandlung von saisonaler allergischer Rhinitis genehmigt hat.

CHENGDU, China, 10 de febrero de 2025 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) ha anunciado hoy que la Administracin Nacional de Productos Mdicos (NMPA) de China ha aprobado recientemente la solicitud de nuevo frmaco complementario (sNDA) de Stapokibart (anticuerpo monoclonal anti-IL-4R, nombre comercial: Kangyueda (), para el tratamiento de la rinitis alrgica estacional.

SO PAULO, Feb. 8, 2025 /PRNewswire/ -- Chef&Nutriwasborn out of the need to encourage healthier living. Focused on the ingestion of nutritionally complete, sustainable and functional foods, based in Bahia, the company is expanding its operations to the Southeast, Midwest and South, in this year of 2025, with numerous innovations, always using the best and most modern has emerged to demystify the idea that healthy food is synonymous with sacrifice, proposing that each meal can be a true celebration of taste and constant well-being.

Global Financial Market Review (GFM) is a dedicated online news aggregation portal specializing in financial market news and industry updates. It combines original editorials with curated content from global news providers, reaching over 14 million readers annually. With a focus on reliability and depth, GFM has positioned itself as a trusted source in the financial sector, boasting a strong social media presence with over 180,000 Twitter followers.

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year

VADUZ, Liechtenstein, Feb. 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStopfor the treatment of acid reflux, a treatment field with 1 billion sufferers, announcesonboarding of the 12thCenter of Excellence in Spain, the La Paz University Hospital in Madrid, one of the most prestigious and world-leading hospitals.

Surgeons in Sweden, Finland and Denmark can now expect enhanced support, seamless service, and expanded access to POLYTECH's cutting-edge breast implant portfolio

BERLIN, Feb. 6, 2025 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 225Ac-SSO110 (satoreotide) for the treatment of patients with Small Cell Lung Cancer (SCLC).

LONDON, Feb. 6, 2025 /PRNewswire/ -- Accord Healthcare Limited (Accord) announced today that the anti-PD-1 mAb, serplulimab, marketed as Hetronifly in Europe, has been officially approved by the European Commission (EC) for use in combination with carboplatin and etoposide as a first-line treatment for ES-SCLC.

- Over $137m of aid distributed to 106 countries from Dubai Humanitarian aid hub used by international organisations including UNICEF, IFRC, WHO and WFP